Nuvectis Pharma
Price & Volume
Stats
See more52W Range | $4.44-$12.10 |
Market Cap | $87.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.16 |
News
See moreYahoo Finance • last year
Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
Yahoo Finance • last year
Nuvectis Pharma Announces Upcoming Poster Presentation for NXP800 at the 2023 AACR Special Conference on Endometrial Cancer
Yahoo Finance • last year
Nuvectis Pharma Announces Updated Date and Time for the 2023 Cantor Global Healthcare Conference Corporate Presentation
Yahoo Finance • last year
Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial
About
CEO | Mr. Ron Bentsur M.B.A. |
Address | 1 Bridge Plaza, Fort Lee, NJ, United States, 07024 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
